Latest Breaking News On - Ronen segman - Page 1 : vimarsana.com

Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE:7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced that it has successfully completed an export of PEX010, the Company's botanical psilocybin drug candidate, to Israel. The shipment is believed to be the first botanical psilocybin to be exported to Israel. Hadassah University Hospital will study PEX010 in a clinical trial examining the effects of psilocybin for treatment-resist

United statesRonen segmanLisa rankenFilament healthProfessor of psychiatry at hadassah university hospitalHadassah university hospitalAssociate professorHadassah universityChief operating officerHadassah university hospitalMental health conditionsDrug candidateFilament health corpClinical trialFilament healthPsychedelic drug